May 31, 2012
/PRNewswire/ -- The Advisory Board Company will describe its innovative use of health care data and introduce new technology capabilities to support Accountable Care Organizations at the Health Data Initiative (HDI) Forum III, also known as the Health Datapalooza, on
at the Washington Convention Center.
"We are excited to be among the diverse group of health care and technology leaders that is coming together to support health care data innovations at the third annual Health Datapalooza," said
, former U.S. Chief Technology Officer and current Senior Advisor, Health Care Technology Strategy at The Advisory Board Company. Mr. Chopra, who will attend the HDI Forum, added, "In the shift toward an accountable care payment landscape, The Advisory Board Company is at the forefront in helping hospitals and health systems improve quality, control costs, and optimize health care utilization through centralized population risk management. We look forward to inspiring discussion and new innovative solutions to improve our nation's health care system."
, Managing Director of Performance Technologies at The Advisory Board Company, will join
and others at a breakout presentation at the HDI Forum entitled "Accountable Care Organizations: Using Data to Deliver Patient-Centered Care and Improve Population Health While Lowering Costs," in Room 103A from
1:30-4:30 pm EDT on Wednesday
, June 6.
Mr. Cinque's presentation will highlight new functionality from The Advisory Board Company's Crimson (R) program that connects sophisticated population analytics with direct patient care. Specifically, the presentation will explain how leading hospitals and health systems can use Crimson to identify high-risk patients and support active and coordinated care management for these individuals, including at the point of care. By bringing together leading-edge analytic and workflow technologies developed in partnership with Milliman MedInsight and the
University of Michigan
, Crimson helps provider organizations secure new needed capabilities and bridge the often-siloed worlds of analysis and action.
"Payers have had solid population risk analytics for years," Mr. Cinque said, "but they have been unable to meaningfully inflect patient care and outcomes. Providers have a better chance of moving the dial, but only if they're able to connect these analytics to patient-level decisions and coordination. Crimson now offers hospitals and health systems that opportunity."